CLINICAL_TRIALS
trial_result
· 2011-06-27
Clinical Trial Update: Effect of PF-00734200 in Subjects With Type 2 Diabetes [Phase 2]
Summary
Phase 2 trial of PF-00734200 in Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED